Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study

BACKGROUND: Biologically naïve patients with inflammatory bowel disease treated with vedolizumab (VDZ) are largely underrepresented in real-world cohorts. A multi-centre, observational cohort study was performed on the effectiveness and safety of VDZ in biologically naïve subjects with Crohn’s disea...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:United European Gastroenterol J
Κύριοι συγγραφείς: Macaluso, Fabio Salvatore, Fries, Walter, Renna, Sara, Viola, Anna, Muscianisi, Marco, Cappello, Maria, Guida, Laura, Siringo, Sebastiano, Camilleri, Salvatore, Garufi, Serena, Privitera, Antonino Carlo, Belluardo, Nunzio, Giangreco, Emiliano, Bertolami, Carmelo, Vassallo, Roberto, Rizzuto, Giulia, Orlando, Rosalba, Ventimiglia, Marco, Orlando, Ambrogio
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: SAGE Publications 2020
Θέματα:
Original Articles
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724546/
https://ncbi.nlm.nih.gov/pubmed/32772830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640620948802
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια